Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for an innovative event with its iNovation® Day in Barcelona, Spain, on Friday 6 September 2024 at the Fira Barcelona Gran Via. Scheduled to be held prior to…

Rayner announced the launch of the RayOne Hydrophobic BLF, Rayner’s first blue light filtering intraocular lens. RayOne Hydrophobic BLF, made of Rayner’s patented ultra glistening-free hydrophobic material, expands Rayner’s RayOne lens from seven to eight variants. The lens provides surgeons…

Artificial intelligence (AI) is emerging as a valuable tool in diagnosing infectious keratitis (IK), a leading cause of corneal blindness worldwide. A recent study published in eClinicalMedicine has shown that deep learning (DL) models demonstrate similar diagnostic accuracy to ophthalmologists…

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, handed the prestigious Ophthalmology Star Awards 2024 (OSA) to its owners during the Satellite Symposium at the ESCRS 2024 Congress in Barcelona. The awards, which were personally presented to…

Researchers from the University Hospital Bonn (UKB) and the University of Bonn have recently explored the intricate connection between tiny eye movements, sharp vision, and the mosaic arrangement of cones in the retina. Using high-resolution imaging techniques and advanced micro-psychophysics,…

A collaborative team of international researchers is exploring the potential of artificial intelligence (AI) in ophthalmology to assess cardiovascular risks by analyzing retinal images. The study has been detailed in a position paper published in the Asia-Pacific Journal of Ophthalmology.…

Cambium Bio Limited, a clinical-stage regenerative medicine company, announced that it has successfully completed an A$3.0 million capital raising round. This funding will primarily support the development of Elate Ocular, a novel treatment for dry eye disease (DED), through registration-enabling…

EyePoint Pharmaceuticals has successfully dosed the first patient in the LUCIA trial, marking the start of the company’s second global Phase 3 clinical study for Duravyu (formerly EYP-1901), an investigational sustained-release therapy for wet age-related macular degeneration (wet AMD). Duravyu:…

AOAExcel, a for-profit subsidiary and member-benefit arm of the American Optometric Association (AOA), has announced its first-ever endorsement of an Electronic Health Records (EHR) system—Barti Software. This partnership includes a financial investment in the San Francisco-based EHR provider, marking a…

The National Health Service (NHS) England is launching a nationwide program to make optical coherence tomography (OCT) scans more accessible, aiming to improve outcomes for patients with diabetic retinopathy. This initiative will bring advanced imaging technology closer to home for…